Viewing Study NCT00723359


Ignite Creation Date: 2025-12-24 @ 3:00 PM
Ignite Modification Date: 2025-12-28 @ 3:37 AM
Study NCT ID: NCT00723359
Status: COMPLETED
Last Update Posted: 2013-07-18
First Post: 2008-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Biotest Pharmaceuticals Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module